(Q50700900)

English

Combination of osteopontin with peritumoral infiltrating macrophages is associated with poor prognosis of early-stage hepatocellular carcinoma after curative resection.

scientific article published on 24 December 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/24366422

Combination of osteopontin with peritumoral infiltrating macrophages is associated with poor prognosis of early-stage hepatocellular carcinoma after curative resection. (English)

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/24366422

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

author name string

Wenwei Zhu

1

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/24366422

Lei Guo

2

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/24366422

Bo Zhang

3

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/24366422

Lili Lou

4

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/24366422

Zhenghai Lin

5

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/24366422

Xiaodong Zhu

6

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/24366422

Ning Ren

7

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/24366422

Qiongzhu Dong

8

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/24366422

Qinghai Ye

9

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/24366422

Lunxiu Qin

10

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/24366422

publication date

24 December 2013

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/24366422

Annals of Surgical Oncology

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/24366422

21

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/24366422

4

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/24366422

1304-1313

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/24366422

https://scigraph.springernature.com/pub.10.1245/s10434-013-3445-0

0 references

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3445-0

21 January 2018

A decade's studies on metastasis of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3445-0

21 January 2018

Management of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3445-0

21 January 2018

Tumor-host interactions: a far-reaching relationship

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3445-0

21 January 2018

Tumour-educated macrophages promote tumour progression and metastasis

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3445-0

21 January 2018

Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3445-0

21 January 2018

Tumor-associated macrophages: the double-edged sword in cancer progression.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3445-0

21 January 2018

Tumor-derived hyaluronan induces formation of immunosuppressive macrophages through transient early activation of monocytes

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3445-0

21 January 2018

Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3445-0

21 January 2018

Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3445-0

21 January 2018

Lentiviral-mediated miRNA against osteopontin suppresses tumor growth and metastasis of human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3445-0

21 January 2018

Thrombin is a therapeutic target for metastatic osteopontin-positive hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3445-0

21 January 2018

Osteopontin (OPN) may facilitate metastasis by protecting cells from macrophage NO-mediated cytotoxicity: evidence from cell lines down-regulated for OPN expression by a targeted ribozyme

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3445-0

21 January 2018

Cytokeratin 10 and cytokeratin 19: predictive markers for poor prognosis in hepatocellular carcinoma patients after curative resection

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3445-0

21 January 2018

Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3445-0

21 January 2018

P48 is a predictive marker for outcome of postoperative interferon-alpha treatment in patients with hepatitis B virus infection-related hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3445-0

21 January 2018

Design and endpoints of clinical trials in hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3445-0

21 January 2018

Osteopontin combined with CD44, a novel prognostic biomarker for patients with hepatocellular carcinoma undergoing curative resection

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3445-0

21 January 2018

Oligonucleotide microarray for prediction of early intrahepatic recurrence of hepatocellular carcinoma after curative resection.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3445-0

21 January 2018

Osteopontin: role in cell signaling and cancer progression

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3445-0

21 January 2018

Osteopontin: regulation in tumor metastasis

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3445-0

21 January 2018

Osteopontin in macrophage function

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3445-0

21 January 2018

Identifiers

10.1245/S10434-013-3445-0

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/24366422

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/24366422

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50700900&oldid=1535805982"